This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Jinbiao Liu: Innovator in Anti-Cancer Research
Introduction
Jinbiao Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of anti-cancer research, holding a total of 2 patents. His work focuses on developing innovative compounds that can serve as potential therapeutic agents.
Latest Patents
Among his latest patents is the invention of Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents. This invention provides a compound of Formula (I) that has the potential to inhibit NSD2, a target in cancer treatment. The implications of this research could lead to new avenues in cancer therapy.
Career Highlights
Throughout his career, Jinbiao Liu has worked with notable organizations such as Novartis AG and the University of Pennsylvania. His experience in these prestigious institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jinbiao Liu has collaborated with esteemed colleagues, including Haibing Deng and Counde Oyang. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Jinbiao Liu is a dedicated inventor whose work in anti-cancer research is paving the way for innovative treatments. His contributions to the field are noteworthy and continue to inspire future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile